Stanford University
Showing 27,851-27,900 of 36,192 Results
-
Londa Schiebinger
John L. Hinds Professor of the History of Science
BioLonda Schiebinger is the John L. Hinds Professor of History of Science in the History Department at Stanford University and Director of the EU/US Gendered Innovations in Science, Health & Medicine, Engineering, and Environment Project. From 2004-2010, Schiebinger served as the Director of Stanford's Clayman Institute for Gender Research. She is a member of the American Academy of Arts and Sciences.
Professor Schiebinger received her Ph.D. from Harvard University in 1984 and is a leading international authority on gender in science and technology. Over the past thirty years, Schiebinger's work has been devoted to teasing apart three analytically distinct but interlocking pieces of the gender and science puzzle: the history of women's participation in science; gender in the structure of scientific institutions; and the gendering of human knowledge.
Londa Schiebinger presented the keynote address and wrote the conceptual background paper for the United Nations' Expert Group Meeting on Gender, Science, and Technology, September 2010 in Paris. She presented the findings at the United Nations in New York, February 2011 with an update spring 2014. In 2022, she prepared the background paper for the United Nations 67th session of the Commission on the Status of Women’s priority theme, Innovation and Technological Change, and Education in the Digital Age for Achieving Gender Equality and The Empowerment of all Women and Girls. Since 2023, Gendered Innovations has been a member of the UNFPA Equity 2030 Alliance.
In 2011-2014, Schiebinger entered into major collaborations with the European Commission and the U.S. National Science Foundation to promote Gendered Innovations in Science, Health & Medicine, Engineering, and Environment. This project draws experts from across the U.S., Europe, Canada, and Asia, and was presented at the European Parliament, July 2013 as Gendered Innovations: How Gender Analysis Contributes to Research. In 2018-2020, Schiebinger directed the European Commission Expert Group to produce Gendered Innovations 2: How Inclusive Analysis Contributes to Research and Innovation. Institutes for Gendered Innovations research opened in Soeul, South Korea, in 2015 and in Tokyo, Japan, in 2022.
Schiebinger’s work has been featured in Science: A Framework for Sex, Gender, and Diversity Analysis in Research: Funding Agencies Have Ample Room to Improve Their Policies (2022); Nature: Sex and Gender Analysis Improves Science and Engineering (2019); Nature: Design AI so that it's Fair (2018); Nature: Accounting for Sex and Gender Makes for Better Science (2020).
Her work in the eighteenth century investigates the circulation of knowledge in the Atlantic World. Her Secret Cures of Slaves: People, Plants, and Medicine in the Eighteenth-Century Atlantic World reconceptualizes research in four areas: first and foremost knowledge of African contributions to early modern science; the historiography of race in science; the history of human experimentation; and the role of science in the eighteenth-century Atlantic world. Her prize-winning Plants and Empire: Colonial Bioprospecting in the Atlantic World investigates women's indigenous knowledge of abortifacients and why this knowledge did not travel.
Londa Schiebinger has been the recipient of numerous prizes and awards, including the prestigious Alexander von Humboldt Research Prize and John Simon Guggenheim Fellowship. She was awarded an honorary doctorate from the Vrije Universiteit Brussel, Belgium (2013), the Faculty of Science, Lund University, Sweden (2017), and the University of Valencia, Spain (2018); the Berlin Falling Walls Breakthrough Winner in Science & Innovation Management (2022). Her work has been translated into numerous languages. In 2022/23, she served as an advisor to the Berlin University Alliance. -
Jenny Clark Schiff
Affiliate, Department Funds
Fellow in SoM - Biomedical EthicsBioJenny Clark Schiff, PhD, MA, MA is the Clinical Ethics Fellow at the Stanford Center for Biomedical Ethics. She has research interests in reproductive ethics, disability ethics, and bioethical issues in sport (especially in the youth/pediatric setting). As part of her fellowship training, she is an Ethics Consultant and member of the Ethics Committee for both Stanford Health Care and Stanford Children's Health.
Dr. Schiff completed her PhD in Philosophy at The Graduate Center of The City University of New York in 2024. Her dissertation focused on poorly understood medical conditions that are, in large part, “invisible” but can be profoundly disabling to patients (e.g. myalgic encephalomyelitis/chronic fatigue syndrome, Long COVID, and postural orthostatic tachycardia syndrome). She is interested in how to improve the doctor-patient relationship in settings of uncertainty, and how to better design healthcare systems and medical education to care for patients with poorly understood medical conditions in a more just and humane manner.
While pursuing her PhD, she was an Ethics Fellow, and then a Senior Ethics Fellow, at the Icahn School of Medicine at Mount Sinai, where she facilitated ethics didactic sessions for medical students and various residency programs. She has also taught or assistant taught bioethics and philosophy courses to graduate students at New York University and undergraduate students at The City College of New York.
Dr. Schiff was a four-year member of the Varsity Women’s Lacrosse team as an undergraduate at Columbia and served as Co-Captain her senior year. She is a cellist in the Stanford Medicine Orchestra and enjoys following international women’s soccer. -
Debra Schifrin
Spring CSP Instructor
BioDebra Schifrin designs and leads corporate workshops on leadership, communication, collaboration, agility, storytelling, and creativity. At Stanford Graduate School of Business, she co-designed, piloted and teaches the school’s first improv-based MBA management course. The course empowers students to become better leaders, managers, and team members. It is one of the only such MBA courses in the world. She is co-creating and teaching a new MBA course in Spring 2021,"Creativity and the Business Ecosystem." Debra has written and published over 80 Stanford and Harvard business cases, which are taught in MBA classes at the GSB and at other business schools. The topics of her business cases include strategy; marketing; product and social innovation; humor; and storytelling.
Before joining Stanford, Debra spent 11 years as a reporter, director and producer for National Public Radio and Marketplace. She produced thousands of breaking news and feature stories for the NPR flagship news program All Things Considered and directed the broadcast. Her stories and commentaries aired on All Things Considered, Morning Edition and Marketplace. A long-time actor and improvisor, Debra performs most weekends in San Francisco in many formats, including improvised musicals and improvised Star Trek. -
Erika Schillinger
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsMy passion is clinical skills education: the patient's experience of health and healthcare, doctor-patient communication, professionalism and physical exam. I am focused on curriculum design and innovation, having helped develop the Continuity of Care Clerkship, the clinical skills curriculum in Practice of Medicine, the Family Medicine core clerkship, outpatient faculty development modules and the SHIELD course (Stanford Healthcare Innovations and Experiential Learning Directive).
-
Christine Schirmer
Director, Teaching and Mentoring Academy, SoM - Teaching and Mentoring Academy
Current Role at StanfordDirector, Teaching and Mentoring Academy
-
Alain Schläpfer
Social Science Research Scholar
BioAlain Schläpfer is a Social Science Research Scholar at the Center on Democracy, Development and the Rule of Law, and a Lecturer in the Ford Dorsey Master's in International Policy. His research examines the evolution of cooperation among individuals and groups, with a particular emphasis on the role of reputational concerns. He also investigates the formation of preferences and of cultural norms, as well as their effects on behavior and long term outcomes. Alain's research has been published in journals in political science, economics and biology, and makes use of formal modelling, causal identification and computer simulations. Originally from Switzerland, Alain received his PhD from Universitat Pompeu Fabra in Barcelona, Spain.
-
Monika Schleier-Smith
Associate Professor of Physics
Current Research and Scholarly InterestsIn between the few-particle realm where we have mastered quantum mechanics and the macroscopic domain describable by classical physics, there lies a broad swath of territory where quantum effects are relevant but still largely out of our control and partly beyond our comprehension. This territory includes metrological instruments whose precision is limited by the quantum projection noise of millions of atoms; and materials whose bulk properties emerge from many-body interactions intractable to simulation on classical computers. Professor Schleier-Smith’s research aims to advance our control and understanding of many-particle quantum systems by engineering new quantum states and Hamiltonians with ensembles of laser-cooled atoms.
-
Noelle Schlenk
Rsch Data Analyst 1, Pediatrics - Rheumatology
BioNoelle is a Research Data Analyst for the Immune Behavioral Health Clinic / research team. She applies her expertise in statistics and bioinformatics to investigate genetic components of Pediatric Acute-onset Neuropsychiatric Syndrome (PANS).
Noelle holds a master's degree in Ecology & Evolutionary Biology from the University of Kansas. -
Adam Craig Schlifke
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Schlifke is a board-certified anesthesiologist and former medical director with fundamental business training highly motivated to improve healthcare delivery in the US through technology. He enjoys working in entrepreneurial environments that are focused on designing innovative solutions that are well integrated into the healthcare workflow. Dr. Schlifke loves to "disrupt" healthcare delivery with technology-enabled services.
-
Gavin Schlissel
Assistant Professor of Chemical and Systems Biology
Current Research and Scholarly InterestsI am interested in understanding how interactions between signaling proteins and the extracellular matrix affect the function and evolution of animal signaling networks. My work touches on many themes in animal biology, including developmental biology, immunology, aging and metabolism.
-
Laura Schlosberg
Academic Prog Prof 3, H&S Dean's Office
Current Role at StanfordAssistant Dean of Academic and Curriculum Support, School of Humanities and Sciences.
-
Mariana Schmajuk
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioMariana Schmajuk received her medical school education at Boston University School of Medicine in 2012. She completed her General Adult Psychiatry Residency program Mount Sinai School of Medicine in New York in 2016, serving as Chief Resident with a focus on the early transition from medical school to residency. She went on to complete her Consult-Liaison fellowship at New York-Presbyterian Hospital Columbia University Medical Center in 2017.
Dr. Schmajuk joined Stanford University CLP team in 2017. She is a primary member of the emergency medicine consultations, working collaboratively with a nurse practioner, social worker and residents. Clinically, Dr. Schmajuk focuses on treating patients with terminal neurological disorders and oncological processes. Dr. Schmajuk is the director of the Psychosomatic Continuity clinic where residents and fellows are able to assess and longitudinally treat patients with psychiatric sequela in the context of complex medical illness. She has a particular interest in brief psychotherapeutic interventions. She enjoys teaching medical students about CL psychiatry and interviewing skills. At present, Dr. Schmajuk is using techniques of applied improvisation to educate psychiatry residents and others about the building blocks of communication. She also is an active member of the bioethics committee. -
John F. Schmerge
Business Operations Manager, SLAC National Accelerator Laboratory
Current Role at StanfordSLAC Accelerator Directorate Associate Laboratory Director
-
Michael F. Schmid
Casual - Nonexempt, SLAC National Accelerator Laboratory
BioI have had more than five decades of experience in Structural Biology. I was a co-Director of a Biomedical Technology Research Resource Center, the National Center for Macromolecular Imaging, NCMI, supported by a P41 grant for thirty years. I am currently a co-Director of a National CryoEM Service Center for Cryoelectron Microscopy, the Stanford-SLAC CryoEM Center, S2C2, and of a part of the National Network for CryoET, the Stanford-SLAC CryoET Specimen Preparation Center, SCSC.
-
Ludwig Schmidt
Assistant Professor of Computer Science
BioLudwig Schmidt is an assistant professor at Stanford University in the Computer Science Department and Stanford Data Science. Ludwig’s research interests revolve around the empirical foundations of machine learning, often with a focus on datasets, reliable generalization, multimodality, and language models. Recently, Ludwig’s research group contributed to open source machine learning by creating OpenCLIP, DCLM, and the LAION-5B dataset. Ludwig completed his PhD at MIT and was a postdoc at UC Berkeley. Ludwig’s research received a new horizons award at EAAMO, best paper awards at ICML & NeurIPS, a best paper finalist at CVPR, and the Sprowls dissertation award from MIT.
-
Peter Schmidt
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioPete Schmidt, MD, MSc is an Assistant Clinical Professor in the Department of Anesthesiology, Perioperative, and Pain Medicine, Division of Pain Medicine at Stanford University School of Medicine, where he conceptualized and launched the Stanford Cancer Pain program. He provides comprehensive and individualized care for patients with cancer-related pain, including patients who are suffering from the effects of cancer treatment. His clinical expertise also includes ultrasound-guided nerve blocks, perioperative pain management, and safe medication tapering after definitive cancer treatment. He is board-certified in Anesthesiology, Pain Medicine, and Addiction Medicine.
Dr. Schmidt's research interests are in clinical trials, drug development, and novel regulatory endpoints. He has designed and led over a dozen clinical trials in the fields of pain management, neurology, infectious diseases, and rare diseases. Dr. Schmidt has published his research findings in several high-impact journals, including Science: Translational Medicine and the New England Journal of Medicine. He is also the author of several book chapters on pain management and perioperative management. -
Leonard Schmieding
Overseas Studies - Berlin, Bing Overseas Studies
BioI studied English, American Studies, History, and History Education at universities in Germany (Freiburg im Breisgau, Leipzig) and the U.S. (Indiana). In 2011, I received my PhD from the University of Leipzig with a dissertation on hip-hop culture in communist East Germany. Since then, I have been a researcher, educator, and public historian in the San Francisco Bay Area, Washington, DC, Münster, and Berlin. While I continue to be interested in youth cultures, migration, and public memory, I am now focusing on building networks between museums, memorials, archives, schools, and universities to use the power of history for active citizenship in our societies in Germany and the U.S. I bring together scholars, curators, and educators in partnerships and professional development, and I work with students, both in secondary schools and at university, to use museum resources for deep historical learning.
-
Paul Schmiedmayer
Instructor, Biodesign Program
Research Engineer, School of Medicine - MDRP'S - Biodesign ProgramCurrent Research and Scholarly InterestsDr. Schmiedmayer's research investigates scalable, intelligent, data-driven systems that leverage patient data and connected devices to provide real-time, personalized healthcare. He aims to validate these solutions by deploying AI-based models on resource-constrained, patient-facing devices, such as smartphones and smart devices, ensuring that personalized medicine is both cost-effective and privacy-preserving.
